22% of people with Medicare had a diagnosis of obesity in 2022, which is more than double the number from a decade earlier and it's believed many more people suffer from obesity without an official diagnosis, CMS administrator Brooks-LaSure said
Ngoupo PA, Sadeuh-Mba SA, De Oliveira F, Ngono V, Ngono L, Tchendjou P, Penlap V, Mourez T, Njouom R, Kfutwah A, Plantier JC
Researchers should also be aware of potential discontinuation effects when stopping Retatrutide administration, as these may impact experimental outcomes and require careful consideration in research protocols
A landmark 2026 Lancet consensus recently renamed PCOS to PMOS (polyendocrine metabolic ovarian syndrome)
The drugmaker Altimmune says its new weekly injectable, pemvidutide, saw patients lose about 75% fat and only 25% muscle in results of a Phase II clinical trial the company announced on Wednesday